SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-04-000005
Filing Date
2004-03-12
Accepted
2004-03-12 15:40:43
Documents
17
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 2003 10-K ligand200310k.htm 10-K 1108639
3 EXHIBIT 10.264 ex10-264.txt EX-10 10458
4 EXHIBIT 10.265 ex10-265.txt EX-10 15867
5 EXHIBIT 10.266 ex10-266.txt EX-10 126413
6 EXHIBIT 10.267 ex10-267.txt EX-10 86685
7 EXHIBIT 10.268 ex10-268.txt EX-10 32746
8 EXHIBIT 10.269 ex10-269.txt EX-10 29197
9 EXHIBIT 10.270 ex10-270.txt EX-10 5633
10 EXHIBIT 10.271 ex10-271.txt EX-10 28271
11 EXHIBIT 10.272 ex10-272.txt EX-10 25854
12 EXHIBIT 14.1 ex14-1.txt EX-14 31284
13 EXHIBIT 21.1 ex21-1.txt EX-21 1074
14 EXHIBIT 23.1 ex23-1.txt EX-23 857
15 EXHIBIT 31.1 ex31-1.txt EX-31 3193
16 EXHIBIT 31.2 ex31-2.txt EX-31 3178
17 EXHIBIT 32.1 ex32-1.txt EX-32 1839
18 EXHIBIT 32.2 ex32-2.txt EX-32 1828
  Complete submission text file 0000886163-04-000005.txt   1516300
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 04666046
SIC: 2834 Pharmaceutical Preparations